R. Flick and M. Bouloy, Rift Valley Fever Virus, Current Molecular Medicine, vol.5, issue.8, p.827, 2005.
DOI : 10.2174/156652405774962263
URL : https://hal.archives-ouvertes.fr/hal-00246555

D. H. Morikawa and . Bishop, Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses, Virology, vol.180, p.738, 1991.

R. Muller, J. F. Saluzzo, N. Lopez, T. Dreier, M. Turell et al., Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment, Am J Trop Med Hyg, vol.53, p.405, 1995.

E. Jacob, M. Bonnefoy, and . Bouloy, A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells, PLoS Pathog, vol.4, p.13, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00246555

H. Superti-furga, F. Unger, and . Weber, NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase, J Virol, vol.83, p.4365, 2009.

T. Ikegami, K. Narayanan, S. Won, W. Kamitani, C. J. Peters et al., Rift Valley fever virus NSs protein promotes post-transcriptional 32 ISG20, an actor of the innate immune response, Biochimie, vol.89, p.831, 2007.

R. T. Barber, J. Lin, and . Hiscott, Transcriptional profiling of interferon regulatory factor 3 target genes: Direct involvement in the regulation of interferonstimulated genes, Journal Of Virology, vol.76, p.5532, 2002.

T. Mashimo, D. Simon-chazottes, and J. L. Guenet, Innate Resistance to Flavivirus Infections and the Functions of 2???-5??? Oligoadenylate Synthetases, Curr Top Microbiol Immunol, vol.321, p.85, 2008.
DOI : 10.1007/978-3-540-75203-5_4

M. Bouloy, C. Janzen, P. Vialat, H. Khun, J. Pavlovic et al., Genetic Evidence for an Interferon-Antagonistic Function of Rift Valley Fever Virus Nonstructural Protein NSs, Journal of Virology, vol.75, issue.3, p.1371, 2001.
DOI : 10.1128/JVI.75.3.1371-1377.2001

C. J. Peters, J. A. Reynolds, T. W. Slone, D. E. Jones, and E. L. Stephen, Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator, Antiviral Research, vol.6, issue.5, p.285, 1986.
DOI : 10.1016/0166-3542(86)90024-0

A. Ohba, N. Takaoka, T. Yoshida, and . Taniguchi, IRF-7 is the master regulator of type-I interferon-dependent immune responses, Nature, vol.434, p.772, 2005.

C. Zhao, C. Denison, J. M. Huibregtse, S. Gygi, and R. M. Krug, Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways, Proceedings of the National Academy of Sciences, vol.102, issue.29, pp.10200-10239, 2005.
DOI : 10.1073/pnas.0504754102

P. M. Hassel and . Pitha, ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation, Cell Mol Biol, vol.52, p.29, 2006.

I. Knobeloch, H. W. Horak, and . Virgin, IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses, Proc Natl Acad Sci, vol.104, p.1371, 2007.

S. Eskildsen, J. Justesen, M. H. Schierup, and R. Hartmann, Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family, Nucleic Acids Research, vol.31, issue.12, p.3166, 2003.
DOI : 10.1093/nar/gkg427

. Brinton, Positional cloning of the murine flavivirus resistance gene, Proc Natl Acad Sci, p.9322, 2002.

P. M. Margolis and . Murphy, Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man, PLoS Pathog, vol.5, p.1000321, 2009.

. Despres, The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus, Virology, vol.384, p.216, 2009.